Computer modeling in urology

Urology

Volumn 47, Issue 1, 1996, Pages 14-21

  Kattan, Michael W ^a   Cowen, Mark E ^a   Miles, Brian J ^a,b  

^a ST JOSEPH MERCY HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ANALYSIS; COMPUTER MODEL; COMPUTER PROGRAM; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; STATISTICAL MODEL; UROLOGY;

COMPUTER SIMULATION; DECISION SUPPORT TECHNIQUES; MARKOV CHAINS; NEURAL NETWORKS (COMPUTER); UROLOGY;

EID: 0030061113     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80375-6     Document Type: Review

References (33)

1. White H: Learning in artificial neural networks: a statistical perspective. Neural Comput 1: 425-464, 1989.
2. Kattan MW, and Beck JR: Artificial neural networks for medical classification decisions. Arch Pathol Lab Med 119: 672-677, 1995.
3. Mann NH, and Brown MD: Artificial intelligence in the diagnosis of low back pain. Orthop Clin North Am 22: 303-314, 1991
4. LeCun Y: Modèle connexionistes de l'apprentissage. Doctoral thesis, University of Paris, 1987.
5. Mulsant BH: A neural network as an approach to clinical diagnosis. MD Comput 7: 25-36, 1990.
6. DeRoach JN: Neural networks - an artificial intelligence approach to the analysis of clinical data. Aust Phys Eng Sci Med 12: 100-106, 1989.
7. Baxt WG: Use of an artificial neural network for data analysis in clinical decision-making: the diagnosis of acute coronary occlusion. Neural Comput 2: 480-489, 1990.
8. Maclin PS, Dempsey J, Brooks J, and Rand J: Using neural networks to diagnose cancer. J Med Syst 15: 11-19, 1991.
9. Snow PB, Smith DS, and Catalona WJ: Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol 152: 1923-1926, 1994
10. Mettlin CJ, Lee F, Drago J, and Murphy GP: The American Cancer Society National Prostate Cancer Detection Project: findings on the detection of early prostate cancer in 2425 men. Cancer 67: 2949-2958, 1991.
11. Moul JW, Snow PB, Fernandez EB, Maher PD, and Sesterhenn IA: Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage 1 nonseminomatous testicular cancer. J Urol 153: 1674-1677, 1995.
12. Niederberger CS, Lipshultz LI, and Lamb DJ: A neural network to analyze fertility data. Fertil Steril 60: 324-330, 1993.
13. Lamb DJ, and Niederberger CS: Artificial intelligence in medicine and male infertility. World J Urol 11: 129-136, 1993.
14. Breiman L, Friedman JJ, Olshen RA, and Stone CJ: Classification and Regression Trees. Monterey, CA, Wadsworth, 1984.
15. Kattan MW, Goto Y, Miles BJ, Ohori M, and Scardino PT: Recursive partitioning versus logistic regression in the prediction of clinically important prostate cancer. Med Decis Making 14: 434, 1994.
16. Weinstein MC, and Fineberg HV: Clinical Decision Analysis. Philadelphia, WB Saunders, 1980.
17. Fleming C, Wasson JH, Albertsen PC, Barry MJ, and Wennberg JE: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA 269: 2650-2658, 1993.
18. Beck JR, and Pauker SG: The Markov process in medical prognosis. Med Decis Making 3: 419-458, 1983.
19. Sonnenberg FA, and Beck JR: Markov models in medical decision making: a practical guide. Med Decis Making 13: 322-338, 1993.
20. Beck JR, Kattan MW, and Miles BJ: A critique of the decision analysis for clinically localized prostate cancer. J Urol 152: 1894-1899, 1994.
21. Kattan MW, Miles BJ, Beck JR, and Scardino PT: Reexamination of the decision analysis for clinically localized prostate cancer: age and grade comparisons (abstract 646). 90th Annual Meeting of the American Urological Association, Las Vegas. J Urol 153: 390A, 1995.
22. Kattan MW, Miles BJ, Beck JR, and Scardino PT: Second order monte carlo simulation in the decision to treat clinically localized prostate cancer. Med Decis Making 15: 429, 1995.
23. Miles BJ, and Kattan MW: Computer modeling of prostate cancer treatment: a paradigm for oncologic management? Surg Oncol Clin North Am 4: 361-372, 1995.
24. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, and Detsky AS: Screening for prostate cancer: a decision analytic view. JAMA 272: 773-780, 1994.
25. Cowen ME, Chartrand M, and Weitzel WF: A Markov model of the natural history of prostate cancer. J Clin Epidemiol 47: 3-21, 1994.
26. Goodnough LM, Grishaber JE, Birkmeyer JD, Monk TG, and Catalona WJ: Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology 44: 226-231, 1994.
27. Kattan MW, Eastham JA, Yawn DH, and Scardino PT: A decision analysis of the cost effectiveness of preoperative autologous blood donation prior to radical prostatectomy for clinically localized prostate cancer. Med Decis Making 15: 429, 1995.
28. Munro AJ, and Warde PR: The use of a Markov process to simulate and assess follow-up policies for patients with malignant disease: surveillance for stage 1 nonseminomatous tumors of the testis. Med Decis Making 11: 131-139, 1991.
29. Kattan MW, Adams DA, and Parks MS: A comparison of machine learning with human judgment. J Manage Inf Syst 9: 37-57, 1993.
30. Kattan MW: Inductive expert systems versus human experts. Artif Intell Exp 9 (4): 32-38, 1994.
31. Coy P: A neural net that can pinpoint prostate cancer. Business Week 105, December 12, 1994.
32. Neiderberger CS: Commentary on the use of neural networks in clinical urology. J Urol 153: 1362, 1995.
33. Gann PH, Hennekens CH, and Stampfer MJ: A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA 273: 289-294, 1995.